[E. Baloglu and D. G. Kingston, The taxane diterpenoids, J. Nat. Prod. 62 (1999) 1448-1472.10.1021/np990176i]Search in Google Scholar
[S. B. Horwitz, Taxol (paclitaxel): mechanisms of action, Annals Oncol. 5 (Suppl. 6) (1994) S3-S6.]Search in Google Scholar
[A. K. Singla, A. Garg and D. Aggarwal, Paclitaxel and its formulations, Int. J. Pharm. 235 (2002) 179-192; DOI: 10.1016/S0378-5173(01)00986-3.10.1016/S0378-5173(01)00986-3]Search in Google Scholar
[J. C. Olivier, Drug transport to brain with targeted nanoparticles, NeuroTherapeutics 2 (2005) 108-119.10.1602/neurorx.2.1.108]Search in Google Scholar
[N. R. Saunders, M. D. Habgood and K. M. Dziegielewska, Barrier mechanisms in the brain, I. Adult brain, Clin. Exp. Pharmacol. Physiol. 26 (1999) 11-19.10.1046/j.1440-1681.1999.02986.x]Search in Google Scholar
[J. Kreuter, R. N. Alyautdin, D. A. Kharkevich and A. A. Ivanov, Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles), Brain Res. 674 (1995) 171-174; DOI: 10.1016/0006-8993(95)00023-J.10.1016/0006-8993(95)00023-J]Search in Google Scholar
[C. M. Lopes, J. M. S. Lobo, J. F. Pinto and P. C. Costa, Compressed matrix core tablet as a quick/slow dual component delivery system containing ibuprofen, AAPS PharmSciTech. 8 (2007) E1-E8; DOI: 10.1208/pt0803076.10.1208/pt0803076]Search in Google Scholar
[A. B. Dhanikula and R. Panchagnula, Preparation and characterization of water-soluble prodrug, liposomes and micelles of paclitaxel, Curr. Drug Deliv. 2 (2005) 75-91.10.2174/1567201052772861]Search in Google Scholar
[J. J. Marty, R. C. Oppenheimer and P. Speiser, Nanoparticles - a new colloidal drug delivery system, Pharm. Acta Helv. 53 (1978) 17-23.]Search in Google Scholar
[W. Lin, M. C. Garnett, E. Schacht, S. Davis and L. Illum, Preparation and in vitro characterization of HSA-mPEG nanoparticles, Int. J. Pharm. 189 (1999) 161-170; DOI: 10.1016/S0378-5173(99)00253-7.10.1016/S0378-5173(99)00253-7]Search in Google Scholar
[K. Michaelis, M. M. Hoffman, S. Dreis, E. Herbert, R. N. Alyautdin, M. Michaelis, J. Kreuter and K. Langer, Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain, J. Pharmacol. Exper. Ther. 317 (2006) 1246-1253.10.1124/jpet.105.097139]Search in Google Scholar
[T. Govender, S. Stolnik, M. C. Garnett, L. Illum and S. S. Davis, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J. Control. Release 57 (1999) 171-185; DOI: 10.1016/S0168-3659(98)00116-3.10.1016/S0168-3659(98)00116-3]Search in Google Scholar
[K. Zhang and X. Y. Wu, Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides, Biomaterials 22 (2004) 5281-5291.10.1016/j.biomaterials.2003.12.032]Search in Google Scholar
[Z. Y. Shen, M. Guang-Hui, D. Toshiaki, M. Yasuyuki and Z. G. Su, Preparation and characterization of thermo-responsive albumin nanospheres, Int. J. Pharm. 346 (2008) 133-142; DOI: 10.1016/j.ijpharm.2007.06.004.10.1016/j.ijpharm.2007.06.004]Search in Google Scholar
[S. S. Feng and G. Huang, Effects of emulsifiers on the controlled release of paclitaxel from nanoparticles of biodegradable polymers, J. Control. Rel. 71 (2001) 53-69; DOI: 10.1016/S0168-3659(00)00364-3.10.1016/S0168-3659(00)00364-3]Search in Google Scholar
[R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35. DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9]Search in Google Scholar
[P. L. Ritger and N. A. Peppas, A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices, J. Control. Release 5 (1987) 37-42; DOI: 10.1016/0168-3659(87)90035-6.10.1016/0168-3659(87)90035-6]Search in Google Scholar
[A. K. Philip and K. Pathak, Osmotic flow through assymetric membrane: A means for controlled delivery of drugs with varying solubility, AAPS PharmSciTech. 7 (2006) E1-E11.10.1208/pt070356]Search in Google Scholar
[D. N. Kapoor, F. V. Manvi, R. C. Doijad and S. Dhawan, Prednisolone loaded albumin nanospheres: in-vitro and in-vivo evaluation studies, PDA J. Pharm. Sci. Tech. 62 (2008) 111-124.]Search in Google Scholar
[K. Santhi, S. A. Dhanaraj, A. Ponnusankar and B. Suresh, Study on formulation and targeting efficiency of Amphotericin-B nanoparticles, Indian J. Pharm. Sci. 6 (2000) 421-423.]Search in Google Scholar
[K. Langer, S. Balthasar, V. Vogel, N. Dinauer, H. V. Briesen and D. Schubert, Optimization of the preparation process for human serum albumin (HSA) nanoparticles, Int. J. Pharm. 257 (2003) 169-180; DOI: 10.1016/S0378-5173(03)00134-0.10.1016/S0378-5173(03)00134-0]Search in Google Scholar
[W. Lin, A. G. A. Coombes, M. C. Davies, S. S. Davis and L. Illum, Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method, J. Drug Target. 1 (1993) 237-243; DOI: 10.3109/10611869308996081.10.3109/106118693089960818069565]Search in Google Scholar
[C. Narendra, M. S. Srinath and A. Moin, The study on the effect of formulation variables on in vitro floating time and the release properties of a floating drug delivery system by a statistical optimization technique, Chem. Ind. Chem. Eng. Quart. 14 (2008) 17-26.10.2298/CICEQ0801017N]Search in Google Scholar